Cannabis and immunotherapy: help or harm? new study investigates

NCT ID NCT06206941

Recruiting now Knowledge-focused Sponsor: State University of New York at Buffalo Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study follows 450 cancer patients receiving immunotherapy to see how cannabis use affects their symptoms like pain, sleep, anxiety, and quality of life. Participants complete surveys and daily assessments over a year. The goal is to understand the benefits and risks of cannabis in this group, helping doctors and patients make informed decisions.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: cannabis
What this could lead to: If successful, this study could provide clearer guidance on whether cannabis helps or harms cancer patients on immunotherapy, improving symptom management.
What could go wrong: This is an observational study, not a treatment trial. It cannot prove cause and effect, and results may not apply to all patients. Cannabis use also carries risks like addiction and side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CANCER

Contacts and locations

Locations

Oregon Health and Science University
NOT_YET_RECRUITING

Portland, Oregon, 97239, United States
Thomas Jefferson University
RECRUITING

Philadelphia, Pennsylvania, 19107, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.